Skip to main content
. 2019 Nov 12;10(61):6604–6622. doi: 10.18632/oncotarget.27287

Table 5. Summary of reporting of TMB testing practices reported by 81 included publications.

Genes tested, n (%) 27 (33%) [10, 30, 32–36, 39–41, 44, 46, 48, 55, 63, 70, 71, 73–75, 86, 87, 91, 94, 100, 101, 104]
 Median (range) reported values 315 (15–592)
Mbs tested, n (%) 10 (12%) [16, 33, 40, 45, 54, 63, 70, 71, 81, 84]
 Median (range) reported values 1.1 (0.8–1.2)
Units used for TMB measurement, n (%)
 Mut/Mb 37 (46%) [16, 28, 30, 33–35, 37, 40, 41, 45, 46, 48, 54, 60, 61, 63, 66, 67, 69–87]
 Total mutations 34 (42%) [1, 10, 32, 36, 38, 39, 42–44, 47, 49–51, 53, 55–57, 59, 62, 64, 65, 68, 88–99]
 Both 2 (2%) [31, 100]
 Other units 8 (10%) [27, 29, 52, 101–105]
TMB threshold defined, n (%) 33 (41%) [1, 10, 16, 28, 30, 32–37, 39, 41–44, 48, 51, 54–56, 60, 63, 66, 69–71, 75, 84, 86, 91, 99, 102]
 By mut/Mb 16 (48%) [16, 28, 33, 35, 37, 41, 48, 54, 63, 66, 69–71, 75, 84, 91]
  Median (range) reported values 20 (10–20)
 By percentiles 10 (30%) [1, 30, 34, 36, 44, 51, 56, 60, 86, 99]
  Median (range) reported values 50 (50–85)
 By total mutations 6 (18%) [10, 32, 39, 42, 43, 55]
  Range of reported values 4–242

Abbreviations: mut/Mb, mutations per DNA megabase; TMB, tumor mutational burden.